Coronavirus disease 2019 (COVID-19) is commonly associated with acute respiratory distress syndrome and acute cardiac and renal injuries. However, thromboembolic events are also prevalent in COVID-19. The pathogenesis of COVID-19 hypercoagulability is not well known but may be linked to the cytokine storm induced by a viral infection or endothelial damage that triggers a cascade leading to hypercoagulability. Because vascular endothelium has angiotensin-converting enzyme 2-like lung tissue, COVID-19 targets lung tissue and vascular endothelium, leading to thrombosis. We present a rare case of a young patient with COVID-19 who presented with thrombosis of the cerebral venous system managed with anticoagulation. This case highlights the need for heightened awareness of this atypical but potentially treatable complication of the COVID-19 disease spectrum.
【저자키워드】 SARS-CoV-2, COVID 19, cerebral venous sinus thrombosis, therapeutic anticoagulation, sagittal sinus thrombosis, 【초록키워드】 COVID-19, viral infection, Coronavirus disease 2019, anticoagulation, thrombosis, endothelial damage, COVID-19 disease, target, hypercoagulability, Angiotensin-converting enzyme, acute respiratory distress, Atypical, Trigger, Vascular endothelium, syndrome, lung tissue, pathogenesis of COVID-19, cascade, Thromboembolic event, patient with COVID-19, venous, prevalent, highlight, renal injuries, the cytokine storm, treatable, 【제목키워드】 COVID-19, Complication, cerebral, Sinus,